GB9903784D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB9903784D0
GB9903784D0 GBGB9903784.8A GB9903784A GB9903784D0 GB 9903784 D0 GB9903784 D0 GB 9903784D0 GB 9903784 A GB9903784 A GB 9903784A GB 9903784 D0 GB9903784 D0 GB 9903784D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9903784.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co Ltd
Eli Lilly and Co
Original Assignee
Eli Lilly and Co Ltd
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co Ltd, Eli Lilly and Co filed Critical Eli Lilly and Co Ltd
Priority to GBGB9903784.8A priority Critical patent/GB9903784D0/en
Publication of GB9903784D0 publication Critical patent/GB9903784D0/en
Priority to PCT/GB2000/000469 priority patent/WO2000049017A1/en
Priority to AU24539/00A priority patent/AU2453900A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB9903784.8A 1999-02-18 1999-02-18 Pharmaceutical compounds Ceased GB9903784D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9903784.8A GB9903784D0 (en) 1999-02-18 1999-02-18 Pharmaceutical compounds
PCT/GB2000/000469 WO2000049017A1 (en) 1999-02-18 2000-02-11 1-((indoly azacycloalkyl) alkyl)-2,1, 3-benzothiadiazole 2,2-dioxides exhibiting 5-ht2a receptor activity
AU24539/00A AU2453900A (en) 1999-02-18 2000-02-11 1-((indoly azacycloalkyl) alkyl)-2,1, 3-benzothiadiazole 2,2-dioxides exhibiting5-ht2a receptor activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903784.8A GB9903784D0 (en) 1999-02-18 1999-02-18 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB9903784D0 true GB9903784D0 (en) 1999-04-14

Family

ID=10848067

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9903784.8A Ceased GB9903784D0 (en) 1999-02-18 1999-02-18 Pharmaceutical compounds

Country Status (3)

Country Link
AU (1) AU2453900A (en)
GB (1) GB9903784D0 (en)
WO (1) WO2000049017A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2362381A (en) * 2000-05-18 2001-11-21 Lilly Co Eli Pharmaceutically active indolyl-piperidines
US6844338B2 (en) 2000-05-18 2005-01-18 Eli Lilly And Company Piperidyindoles as serotonin receptor ligands
HUP0400343A2 (en) 2001-03-29 2004-09-28 Bristol-Myers Squibb Co. Cyclopropylindole derivatives as selective serotonin reuptake inhibitors, process for their preparation and pharmaceutical compositions containing them
CN1723209A (en) 2002-12-10 2006-01-18 默克专利有限公司 Indol derivatives and their use as 5-HT ligands
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US20070191453A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction
TW200812573A (en) 2006-05-19 2008-03-16 Janssen Pharmaceutica Nv Co-therapy for the treatment of epilepsy and related disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
US4359468A (en) * 1981-02-25 1982-11-16 Boehringer Ingelheim Ltd. Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
CA1246074A (en) * 1984-12-05 1988-12-06 Albertus H.M.T. Van Heertum Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
FR2621588B1 (en) * 1987-10-08 1991-05-24 Roussel Uclaf NOVEL DERIVATIVES OF 1,1-DIOXO 1,2-BENZOISOTHIAZOL 3-ONE, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
FR2662696A2 (en) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Serotonin antagonists, their preparation and medicaments containing them
GB9700895D0 (en) * 1997-01-17 1997-03-05 Lilly Co Eli Pharmaceutical compounds
WO1999010346A1 (en) * 1997-08-22 1999-03-04 Eli Lilly And Company Limited Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
WO1999014203A1 (en) * 1997-09-16 1999-03-25 Takeda Chemical Industries, Ltd. Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs

Also Published As

Publication number Publication date
WO2000049017A1 (en) 2000-08-24
AU2453900A (en) 2000-09-04

Similar Documents

Publication Publication Date Title
GB9817118D0 (en) Pharmaceutical compounds
PL351387A1 (en) Pharmaceutical composition
AU1071301A (en) Pharmaceutical compounds
GB9817623D0 (en) Pharmaceutical compounds
GB9810886D0 (en) Pharmaceutical compounds
PL351686A1 (en) Novel pharmaceutical
HUP0203585A3 (en) Pharmaceutical combinations
IL145632A0 (en) Pharmaceutical compounds
GB0031084D0 (en) Pharmaceutical compounds
EG23937A (en) Novel pharmaceutical
GB9916434D0 (en) Pharmaceutical compounds
GB9914255D0 (en) Pharmaceutical compounds
PL351135A1 (en) Novel pharmaceutical
GB9823847D0 (en) Pharmaceutical compounds
GB9903784D0 (en) Pharmaceutical compounds
GB9823845D0 (en) Pharmaceutical compounds
IL146341A0 (en) Pharmaceutical complex
EG23946A (en) Novel pharmaceutical
GB0019272D0 (en) Pharmaceutical compounds
GB2373499B (en) Pharmaceutical compounds
GB0024318D0 (en) Pharmaceutical compounds
GB9817197D0 (en) Pharmaceutical compounds
GB0005366D0 (en) Pharmaceutical compounds
GB9923933D0 (en) Novel pharmaceutical
SI1169298T1 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)